Abstract
Background
X-linked cerebral creatine deficiency is caused by the deficiency of the creatine transporter (CTP) encoded by the SLC6A8 gene.
Patients and Methods
We report here a series of six patients with severe CTP deficiency, four males and two females; clinical presentations include mild to severe mental retardation (6/6), associated with psychiatric symptoms (5/6: autistic behaviour, chronic hallucinatory psychosis), seizures (2/6) and muscular symptoms (2/4 males). Diagnosis was suspected upon elevated urinary creatine/creatinine (except in one of the female patients) and on a markedly decreased creatine peak on magnetic resonance spectroscopy (MRS). Diagnosis was confirmed by molecular analysis that identified four novel mutations not reported so far, including a mutation found twice in two male patients. All patients were treated successively and according to the same protocol by creatine alone then combined to its precursors, L-glycine and L-arginine for 42 months.
Results and conclusion
In our patients, creatine supplementation alone or with its precursors L-glycine and L-arginine showed benefit only in the muscular symptoms of the disease and no improvement in the cognitive and psychiatric manifestations and did not modify brain creatine content on MRS of male and female CTP deficient patients. New treatment strategies are required including creatine derivatives transported independently from CTP or using alternative pathways and transporters.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Almeida LS, Verhoeven NM, Roos B et al. (2004) Creatine and guanidinoacetate: diagnostic markers for inborn errors in creatine biosynthesis and transport. Mol Genet Metab 82:214–219
Almeida LS, Salomons GS, Hogenboom F, Jakobs C, Schoffelmeer AN (2006) Exocytotic release of creatine in rat brain. Synapse 60:118–123
Andres RH, Ducray AD, Huber AW et al. (2005a) Effects of creatine treatment on survival and differentiation of GABA-ergic neurons in cultured striatal tissue. J Neurochem 95:33–45
Andres RH, Huber AW, Schlattner U et al. (2005b) Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue. Neuroscience 133:701–713
Anselm IA, Alkuraya FS, Salomons GS et al. (2006) X-linked creatine transporter defect: a report on two unrelated boys with a severe clinical phenotype. J Inherit Metab Dis 29:214–219
Battini R, Alessandrì MG, Leuzzi V et al. (2006) Arginine:glycine amidinotransferase (AGAT) deficiency in a newborn: An early treatment can prevent the phenotypic expression of the disease. J Pediatr 148:828–830
Betsalel OT, Rosenberg EH, Almeida LS et al. (2011) Characterization of novel SLC6A8 variants with the use of splice-site analysis tools and implementation of a newly developed LOVD database. Eur J Hum Genet 19:56–63
Bizzi A, Bugiani M, Salomons GS et al. (2002) X-linked creatine deficiency syndrome: a novel mutation in creatine transporter gene SLC6A8. Ann Neurol 52:227–231
Braissant O, Bachmann C, Henry H (2007) Expression and function of AGAT, GAMT and CT1 in the mammalian brain. Subcell Biochem 46:67–81
Braissant O, Béard E, Torrent C, Henry H (2010) Dissociation of AGAT, GAMT and SLC6A8 in CNS: relevance to creatine deficiency syndromes. Neurobiol Dis 37:423–433
Cecil KM, Salomons GS, Ball WS et al. (2001) Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect? Ann Neurol 49:401–404
Chilosi A, Leuzzi V, Battini R et al. (2008) Treatment with L-arginine improves neuropsychological disorders in a child with creatine transporter defect. Neurocase 14:151–161
Clark AJ, Rosenberg EH, Almeida LS et al. (2006) X-linked creatine transporter (SLC6A8) mutations in about 1% of males with mental retardation of unknown etiology. Hum Genet 119:604–610
de Grauw TJ, Salomons GS, Cecil KM et al. (2002) Congenital creatine transporter deficiency. Neuropediatrics 33:232–238
Dringen R, Verleysdonk S, Hamprecht B, Willker W, Leibfritz D, Brand A (1998) Metabolism of glycine in primary astroglial cells: synthesis of creatine, serine, and glutathione. J Neurochem 70:835–840
Fons C, Sempere A, Arias A et al. (2008) Arginine supplementation in four patients with X-linked creatine transporter defect. J Inherit Metab Dis 31:724–728
Leuzzi V, Bianchi MC, Tosetti M et al. (2000) Brain creatine depletion: Guanidinoacetate methyltransferase deficiency (improving with creatine supplementation). Neurology 55:1407–1409
Leuzzi V, Alessandri MG, Casarano M, Battini R, Cioni G (2008) Arginine and glycine stimulate creatine synthesis in creatine transporter 1-deficient lymphoblasts. Anal Biochem 375:153–155
Mercimek-Mahmutoglu S, Stockler-Ipsiroglu S (2009) Cerebral creatine deficiency syndromes. In: Pagon RA, Bird TD, Dolan CR, Stephens K (eds) Gene Reviews Seattle. University of Washington, Seattle, pp 1993–2009
Mercimek-Mahmutoglu S, Stoeckler-Ipsiroglu S, Adami A et al. (2006) GAMT deficiency: features, treatment, and outcome in an inborn error of creatine synthesis. Neurology 67:480–484
Mercimek-Mahmutoglu S, Muehl A, Salomons GS et al. (2009) Screening for X-linked creatine transporter (SLC6A8) deficiency via simultaneous determination of urinary creatine to creatinine ratio by tandem mass-spectrometry. Mol Genet Metab 96:273–275
Mercimek-Mahmutoglu S, Connolly MB, Poskitt KJ et al. (2010) Treatment of intractable epilepsy in a female with SLC6A8 deficiency. Mol Genet Metab 101:409–412
Newmeyer A, Cecil KM, Schapiro M et al. (2005) Incidence of brain creatine transporter deficiency in males with developmental delay referred for brain magnetic resonance imaging. J Dev Behav Pediatr 26:276–282
Palmer RM, Ashton DS, Moncada S (1988) Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333:664–666
Rogers RC, Stevenson RE, Simensen RJ et al. (2008) Finding new etiologies of mental retardation and hypotonia: X marks the spot. Dev Med Child Neurol 50:104–111
Salomons GS, van Dooren SJ, Verhoeven NM et al. (2001) X-linked creatine transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome. Am J Hum Genet 68:1497–1500
Sipilä I (1980) Inhibition of arginine-glycine amidinotransferase by ornithine. A possible mechanism for the muscular and chorioretinal atrophies in gyrate atrophy of the choroid and retina with hyperornithinemia. Biochim Biophys Acta 613:79–84
Stockler S, Schutz PW, Salomons GS (2007) Cerebral creatine deficiency syndromes: clinical aspects, treatment and pathophysiology. Subcell Biochem 46:149–166
Stockler-Ipsiroglu S, Salomons GS (2006) Creatine deficiency syndromes. In: Fernandes J, Saudubray JM, van den Berghe G (eds) Inborn Metabolic Diseases. Springer, Berlin, pp 211–217
van de Kamp JM, Mancini GM, Pouwels PJ et al. (2011) Clinical features and X-inactivation in females heterozygous for creatine transporter defect. Clin Genet 79(3):264–272
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by: Carlo Dionisi-Vici
Competing interest: None declared.
Rights and permissions
About this article
Cite this article
Valayannopoulos, V., Boddaert, N., Chabli, A. et al. Treatment by oral creatine, L-arginine and L-glycine in six severely affected patients with creatine transporter defect. J Inherit Metab Dis 35, 151–157 (2012). https://doi.org/10.1007/s10545-011-9358-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-011-9358-9